Orville Campbell, MD, MBA Chief Executive Officer

Dr. Orville C. Campbell is a physician executive, strategist, and problem-solving leader known for building high-performing healthcare systems, strengthening operational performance, and turning complex challenges into clear, measurable solutions. As CEO of CD Solomon, he brings decades of experience in clinical leadership, healthcare consulting, strategy, performance improvement, and medical-legal analysis, with a reputation for bringing clarity, discipline, and results when the stakes are high.

Dr. Campbell has led the development and advancement of programs across nephrology, dialysis, primary care, cardiovascular risk, correctional healthcare, utilization management, and population health. His work is defined by execution. He has built multi-disciplinary teams, aligned clinical and operational priorities, and developed practical systems that improve quality, accountability, and long-term performance. His leadership consistently centers on one outcome: helping organizations move forward with stronger strategy, sharper execution, and measurable gains.

In his role as Epidemiologist, Strategist, and Performance Measurement Lead for the Behavioral Health and Wellness Division of the Metro Public Health Department of Nashville and Davidson County, Dr. Campbell led divisional strategy, analytics, and clinical performance infrastructure across nine programmatic areas. He helped shape the countywide Opioid System of Care, founded the Nashville Adult Opioid Overdose and Suicide Fatality Review Panel, architected the division’s five-year strategic plan, and advanced executive dashboards and KPI frameworks that strengthened decision-making, cross-sector alignment, and measurable accountability.

Dr. Campbell is recognized for his ability to move organizations from concept to execution. He has co-designed clinical models, operationalized performance metrics, developed physician leaders, and embedded specialty services within larger systems in ways that strengthen outcomes, reduce risk, and improve sustainability. His career reflects a clear pattern of building what works, correcting what does not, and creating the infrastructure leaders need to perform at a higher level.

He has also served on advisory boards for Gambro Healthcare, Shire Pharmaceuticals, and Abbott Pharmaceuticals, providing senior guidance on quality, strategy, and regulatory-aligned medical communications. He delivered performance recommendations across a 276-clinic dialysis footprint to improve clinical consistency and quality at scale, supported launch planning and compliance strategy for major pharmaceutical initiatives, and served as a national speaker for Amgen, Genzyme, and Novartis on complex medical topics including end-stage kidney disease, anemia, hypertension, and metabolic bone disease.

As CEO of CD Solomon, Dr. Campbell brings that same high-level discipline and strategic rigor to every engagement. Whether the need is healthcare consulting and strategy, expert witness support, or life and career coaching, his focus is the same: solve the problem, create a clear path forward, and deliver results that stand up.